AFFIX Labs and leading seat manufacturer Franz Kiel GmbH sign agreement to use Si-Quat

AFFIX Labs and leading seat manufacturer Franz Kiel GmbH sign agreement to use Si-Quat
  • 27.04.2021

Every day, millions of people depend on public transportation, and it will be critical to the opening of economies following the COVID-19 lockdowns around the world. Many viruses and bacteria, including the SARS-COV-2 virus, can live on certain surfaces for up to three days, making frequently touched areas in public spaces possible cross-contamination hot spots.

As people around the world return to buses and trains, AFFIX Labs' robust semi-permanent surface coating Si-Quat, which has been shown to kill 99.9% of bacteria and viruses, including SARS-COV-2, will be helping to make public transportation safer. As people around the world return to buses and trains, AFFIX Labs' robust semi-permanent surface coating Si-Quat, which has been shown to kill 99.9% of bacteria and viruses, including SARS-COV-2, will be helping to make public transportation safer.

Si-Quat helps to prevent cross contamination with a durable layer of polymerized active ingredient that binds to walls, handles, furniture, and other key touch points, staying in place for up to 12 months and killing 99.9% of viruses and bacteria that come into contact with the treated surface. The coating has been tested and certified to be effective against bacteria, viruses, and fungi, and has passed the rigorous EN45545-2 HL3 flammability norm for trains and REG118.3 for busses.

  Kiel has been manufacturing high quality seating for public transport globally for more than 75 years and will now be offering Si-Quat to clients as a new solution to protect travellers on their transport networks. With Si-Quat already registered on several continents a quick roll out is truly achievable.  

“We are delighted to be working with AFFIX Labs to roll out Si-Quat in public transport systems around the world. It’s easy to apply, it works and we have had great support from the AFFIX-Labs team. We hope that our partnership can help to re-open countries and boost passengers trust in once again using public transport,” said Daniel Fräde, Kiel’s Sales Director Bus Division.

  By treating the vast fleets of vehicles that power the mass movement of people in countries all over the world, AFFIX and Kiel Seating can create safe transportation interiors which are a key component of national infrastructures. We are proud to be part of the global effort to build a more future-proof response to COVID-19, and other contagions that have the potential to cause pandemics” concluded Tom Sam, CEO of AFFIX Labs.  

Yazıyı Paylaş